Literature DB >> 22610954

Wilson's disease: update on integrated Chinese and Western medicine.

Wen-Jie Li1, Jun-Feng Wang, Xiao-Ping Wang.   

Abstract

Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive inheritance disorder of copper metabolism caused by ATP7B gene mutation. As WD is an inherited disease of the nervous system that is not curable; early diagnosis with early and life-long treatment leads to better prognoses. Currently, the recommended treatment for WD is integrated Chinese and Western medicine. A number of studies indicate that treatment of integrative medicine can not only enforce the de-copper effect but also improve liver function, intelligence, and other factors. This article reviewed in detail the advantages of WD treated with Chinese and Western medicine together.

Entities:  

Mesh:

Year:  2012        PMID: 22610954     DOI: 10.1007/s11655-012-1089-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  24 in total

Review 1.  Wilson's disease.

Authors:  Aftab Ala; Ann P Walker; Keyoumars Ashkan; James S Dooley; Michael L Schilsky
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

2.  [Clinical study of integrated traditional and Western medicine therapy on hepatolenticular degeneration].

Authors:  M S Ren; B Zhang; R M Yang
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  1997-03

3.  Diagnosis and management of Wilson's disease: results of a single center experience.

Authors:  Valentina Medici; Carlo Pietro Trevisan; Renata D'Incà; Michela Barollo; Lucia Zancan; Stefano Fagiuoli; Diego Martines; Paola Irato; Giacomo Carlo Sturniolo
Journal:  J Clin Gastroenterol       Date:  2006 Nov-Dec       Impact factor: 3.062

4.  [Effect of gandou decoction on copper metabolism of skin fibroblast of hepatolenticular degeneration model].

Authors:  Q Tang; R Yang; Y Han
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2000-01

5.  Wilson's disease: clinical presentation and use of prognostic index.

Authors:  H Nazer; R J Ede; A P Mowat; R Williams
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

6.  Treatment of Wilson's disease with zinc: XV long-term follow-up studies.

Authors:  G J Brewer; R D Dick; V D Johnson; J A Brunberg; K J Kluin; J K Fink
Journal:  J Lab Clin Med       Date:  1998-10

7.  Diagnostic criteria for acute liver failure due to Wilson disease.

Authors:  Christoph Eisenbach; Olivia Sieg; Wolfgang Stremmel; Jens Encke; Uta Merle
Journal:  World J Gastroenterol       Date:  2007-03-21       Impact factor: 5.742

8.  Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease.

Authors:  Xiao-Qing Liu; Ya-Fen Zhang; Tze-Tze Liu; Kwang-Jen Hsiao; Jian-Ming Zhang; Xue-Fan Gu; Ke-Rong Bao; Li-Hua Yu; Mei-Xian Wang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

9.  Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease.

Authors:  Xiao-Ping Wang; Ren-Min Yang; Ming-Shan Ren; Bo-Min Sun
Journal:  Funct Neurol       Date:  2003 Jul-Sep

10.  Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.

Authors:  George J Brewer; Peter Hedera; Karen J Kluin; Martha Carlson; Fred Askari; Robert B Dick; Julia Sitterly; John K Fink
Journal:  Arch Neurol       Date:  2003-03
View more
  12 in total

Review 1.  Wilson's Disease in China.

Authors:  Juan-Juan Xie; Zhi-Ying Wu
Journal:  Neurosci Bull       Date:  2017-03-06       Impact factor: 5.203

Review 2.  Traditional Chinese medicine for modern treatment of Parkinson's disease.

Authors:  Lu Han; Yuan-Hong Xie; Rong Wu; Chen Chen; Yan Zhang; Xiao-Ping Wang
Journal:  Chin J Integr Med       Date:  2017-01-20       Impact factor: 1.978

Review 3.  Epidemiology, diagnosis, and treatment of Wilson's disease.

Authors:  Jing Liu; Jing Luan; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2017-11

4.  Persistence with medical treatment for Wilson disease in China based on a single center's survey research.

Authors:  Zhi-Hua Zhou; Yun-Fan Wu; Yan Yan; Ai-Qun Liu; Qing-Yun Yu; Zhong-Xing Peng; Gong-Qiang Wang; Ming-Fan Hong
Journal:  Brain Behav       Date:  2021-05-05       Impact factor: 2.708

5.  1H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.

Authors:  Jingjing Xu; Huaizhou Jiang; Jinquan Li; Kian-Kai Cheng; Jiyang Dong; Zhong Chen
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

6.  Transplanted Neural Stem Cells: Playing a Neuroprotective Role by Ceruloplasmin in the Substantia Nigra of PD Model Rats?

Authors:  Jia-Jia Xiao; Ming Yin; Ze-Jian Wang; Xiao-Ping Wang
Journal:  Oxid Med Cell Longev       Date:  2015-06-03       Impact factor: 6.543

Review 7.  Currently Clinical Views on Genetics of Wilson's Disease.

Authors:  Chen Chen; Bo Shen; Jia-Jia Xiao; Rong Wu; Sarah Jane Duff Canning; Xiao-Ping Wang
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

8.  Gandouling Tablets Inhibit Excessive Mitophagy in Toxic Milk (TX) Model Mouse of Wilson Disease via Pink1/Parkin Pathway.

Authors:  Jing Zhang; Lu-Lu Tang; Liang-Yong Li; Shen-Wei Cui; Shan Jin; Huai-Zhen Chen; Wen-Ming Yang; Dao-Jun Xie; Gu-Ran Yu
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-14       Impact factor: 2.629

Review 9.  Current Drug Managements of Wilson's Disease: From West to East.

Authors:  Wen-Jie Li; Chen Chen; Zhi-Fei You; Ren-Min Yang; Xiao-Ping Wang
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Association study of gut flora in Wilson's disease through high-throughput sequencing.

Authors:  Hao Geng; Shan Shu; Jianjian Dong; Hai Li; Chenchen Xu; Yongsheng Han; Jiyuan Hu; Yongzhu Han; Renmin Yang; Nan Cheng
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.